Neuronetics is trading 5.11% lower at $2.60, with the broader market’s decline offering context for the move.
- No clear company-specific announcement or catalyst surfaced for September 28, 2026.
- Reuters reported that U.S. stocks fell after President Trump rejected Iran’s proposal, lifting oil prices and reviving inflation concerns; Treasury yields rose.
- Trading volume information was unavailable.